Close Menu

NEW YORK (GenomeWeb) – Hologic reported after the close of the market on Wednesday that its fiscal fourth quarter revenues rose 1 percent, driven in part by growth in its breast health and molecular diagnostics businesses.

For the three months ended Sept. 30, the firm reported revenues of $813.5 million up from $802.9 million a year ago, beating the average consensus Wall Street estimate of $806.6 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
10

This webinar will provide an overview of how a pathology laboratory validated a 77-gene next-generation sequencing-based liquid biopsy assay.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.